Investment Q&A

Q: Greetings to all at 5i. I hope everyone, your family and friends are well. Nuvo recently spun out Crescita Therapeutics. I have done very well in the past when companies have split. I am considering taking my profits now, however, before I do so I would appreciate your analysis. Thank you and my best wishes to all.

Q: Hi guys

Can you look into LND'S latest report and comment it on it?. I bought this around $ .70 and have watched it fo down like the titanic. I liked the fact that they were trading at less than cash on hand and making money, it is baffling me.I was looking for it to rebound or start forming a base before I bought more, in the old days I would have jumped in and averaged down, but now I wait for a reversal, good thing, as it went down 30% today.I do not like the fact that insiders do not own any shares, that I can see, wonder who is unloading.What do you think about this company?
Thank-you and have a nice day.

Auftar

Q: Now that some of the initial panic in the markets after the Brexit vote seems to be settling down, what are your current thoughts regarding the potential sale of the company and probable timing?

Q: Hi 5i,

Say you were to sell shares of CXR.TO in a Canadian Dollar account at a loss and then purchase shares of CXRX.US in a US dollar account. Am I right assume you cannot claim the loss for tax-loss selling because you are ultimately buying the same security?

Thanks, Shane

Q: Good Morning....i would appreciated a quick comment on convalo's latest results please. Thanks...

Q: I know you have mentioned that CXR has gone down with Valeant and that the fundamentals are still good. Yes they have debt but a lot of free cash flow to pay it down. But this stock just continues to fall, to ridiculously low prices. There was also another Seeking Alpha report posted today bashing the company.At what level would you say investors should get out of it, if it continues on this path?

Q: Could you please comment on the G&M article mentioning CXR:
http://www.theglobeandmail.com/globe-investor/investment-ideas/the-top-20-canadian-companies-exposed-to-the-british-pound/article30635313/

Have you seen the CIBC report referenced in it? Could you please share your opinion wrt CXR?

Q: What is your opinion of Prometic Life Science. It was recommended to me by a friend who is in the financial business.
Thank you
Dan

Q: Of course, most all have dropped but - would appreciate your financial & expertize on these 3 US healthcare related stocks. Thank you.

Q: Hi Guys

Do you think it is time to buy some hhl.un units at this time

Thanks Mike B

Q: Hi folks
Two questions.
I have held both these for some time in my wife's LIRA account. She can not access this for about 12 years, so a long term hold is very possible. Have held these for a couple years. Both are down about 10%, I have held on because I see the ETF as a long term play on our aging population, and ACHN (hopefully you have a little info with this) as a risky but likely takeout target down the road. I have trimmed this one down and made a bit of $ in another account with it, so it isn't as bad as it looks.
Looking back, which is always easy, there are better options, however I am in now and wondering if I should stay the course.
Don't mind volatility, actually kind of drawn to it. Any thoughts?
Excellent job btw, your cheap at twice the price!
Cheers ;)

Q: The steep drop in the British pound will have a large impact on Concordia's earnings? Do you know if any of their debt is in the same currency? What would be your assessment of Concordia over the next few quarters?

Q: Because AMCo resides in UK, should that have any bearing on CXR's future performance? Down 10% in early trading today. Or is this a good excuse for the uncommited to bail out of CXR.

Carl

Q: This company appears to have stumbled after a recent purchase--should I hang on for a recovery or take a small loss ???

Q: Could I please get your opinion of this fund for a RESP.

Thanks

Dave

Q: Will you be covering Concordia Healthcare in the future seeing that it is in the growth portfolio (and there are many questions on it)?

Thanks,
Andrew

Q: I purchased nhc at $4.00 it was at $9.00 went to $3.00 then went to $6.00 and now under $3.00 should I take my hard hit, sell and move on?
Thanks,

Q: First bought a small position when it had dropped to $90 from its alt-time of around $117. Averaged down several months ago to a $53 cost and about a 3.5% position. Am thinking about chasing it at its current price of $29 to lower my cost to $40. Can't understand the downward pressure on this stock. I know it has some debt but also strong earnings. Can't help but think of Teck when it was down below $4 not that long ago and now is over $15. I don't like averaging down but it just seems so mis-priced. Forgetting about the short manipulations, do you you see any faundamental downside risk.

Q: Hello team,
thank you for your all your investments answers and for the ones regarding Concordia Healthcare in particular.
Going forward it seems that unfortunately the sentiment towards Biotech stocks, Brexit, the similarities with Valeant, short attacks and other possible concerns with CXR is simply killing the share price and CXR has become a falling knife...

In addition technically speaking it just broke below 2016 lows... Do you still think its buyable now?

Thx again!

Q: Hi Guys,

Can you speak a bit about the adjustments that CXR has been making to its financials? Is this accounting gimmickry? Is the underlying business sustainable without these adjustments?

My thinking is that these acquisition-related adjustments can't be made forever, so won't reality of low unadjusted earnings one day set in?